Back to 
BlackRock, Inc.HAHAE
BlackRock, Inc.HAHAE7 quarters
Position history for BlackRock, Inc.'s holdings in HAEMONETICS CORP MASS
BlackRock, Inc. holds 5.9M shares of HAE (HAEMONETICS CORP MASS), worth $443.2M as of 2026-Q2. The position was increased (+5.2% shares). HAE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$443.2M
Current Shares
5.9M
Total Value Change
-$37.8M
Total Shares Change
-250,646
Quarter-by-Quarter History
Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS